Skip to main content

Table 2 Medication used within the study cohort

From: Disease control in patients with asthma and respiratory symptoms (wheezing, cough) during sleep

Medication n/N (%)
ICS/LABA 37/55 (67,3)
ICS solo 7/55 (12,7)
LAMA 8/55 (14,5)
SABA 39/55 (70,9)
SAMA 4/55 (7,3)
Omalizumab 3/55 (5,5)
Montelukast 7/55 (12,7)
Mepolizumab/Benralizumab 3/55 (5,5)